我的购物车
购物车中还没有商品,赶紧选购吧!
  • 产品名称
  • 规格
  • 数量
  • 总价
    已选择商品 : 0 总计 : 结账()
    Roxadustat (FG-4592)
    Roxadustat (FG-4592)

    售价:
    市场价:

    产品仅用于科学研究,不针对患者销售
    数量: - + 件(库存件)
    InvivoChem目录号 #: V0293
    CAS号码 #: 808118-40-3 纯度 ≥98%

    Description: Roxadustat (FG4592, ASP1517) is a novel, potent and orally bioavailable inhibitor of HIF-PH (hypoxia-inducible factor prolyl hydroxylase) with the potential to treat anemia associated with chronic kidney disease (CKD). HIF-PH is an enzyme that can up-regulate the expression of endogenous human erythropoietin (Epo). Roxadustat induces EPO production and stimulates erythropoiesis. It is currently being investigated as an oral treatment for anemia associated with CKD. 

    References:Nephrol Dial Transplant. 2015 Oct;30(10):1665-73; Stem Cells Transl Med. 2014 Feb;3(2):135-40.

    Customer Validation
    InvivoChem产品被CNS顶刊文章引用
    • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, 597(7874):119-125.
    • Citation of InvivoChem Larotrectinib (V2599) by Cell 2020, 183(5):1202-1218.e25
    • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
    • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, 597(7874):119-125.
    • Citation of InvivoChem Larotrectinib (V2599) by Cell 2020, doi: 10.1016/j.cell.2020.10.016.
    • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, doi: 10.1126/sciadv.abm9427.
    • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
    • Citation of InvivoChem Vitrakvi by Cell 2020, PMID: 33142117 PMCID: PMC8100789
    • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, PMID: 36103522.
    • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
    • Citation of InvivoChem LOXO-101 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
    • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, PMID: 36103522.
    • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, PMID: 34433969
    • Citation of InvivoChem  ARRY-470 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
    • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
    • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, PMID: 34433969
    • Citation of InvivoChem BMH-21 (V1435) by Cell Stem Cell 2020, 26(6): 845-861.e12.
    • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
    • Citation of InvivoChem BMH-21 (V1435) by Cell Stem Cell 2020, 26(6): 845-861.e12.
    • Citation of InvivoChem BMS-582949 (V2668) by Cells 2020, 9(6):1472.
    • Citation of InvivoChem Resveratrol (V0430) by  Arterioscler Thromb Vasc Biol 2020, 40(10):2408
    • Citation of InvivoChem LGK974 /WNT974 (V1353) by  Cancer Cell 2021 Apr 12;39(4):529-547.e7.
    • Citation of InvivoChem V1386 Napabucasin (BBI-608) by J Exp Clin Cancer Res 2021 Oct 13;40(1):319.
    • Citation of InvivoChem S63845 (V2797) by Cell Death and Disease 2020, 11:316.
    • Citation of InvivoChem LGK974 /WNT974 (V1353) by  Cancer Cell 2021 Apr 12;39(4):529-547.e7.
    • Citation of InvivoChem Apiin (V4467) by J Med Chem 2020, 63(15):8338-8358.
    • Citation of InvivoChem V0001 venetoclax by WO2021231323A1
    顾客使用 InvivoChem产品发表科研文献
    • 产品理化性质和储存条件
    • 实验参考方法
    • 质控文件
    • 生物活性
    • 顾客评价

    Molecular Weight (MW)

    352.34

    Formula

    C19H16N2O5

    CAS No.

    808118-40-3

    Storage

    -20℃ for 3 years in powder form

    -80℃ for 2 years in solvent

    Solubility (In vitro)

    DMSO: 70 mg/mL (198.7 mM)

    Water: <1 mg/mL

    Ethanol: <1 mg/mL

    Solubility (In vivo)

    5% DMSO+50% PEG 300+ddH2O: 11mg/mL

    Synonyms

    Roxadustat; ASP1517; ASP 1517; ASP-1517; FG-4592; FG4592; FG-4592;

    Chemical Name: (4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)glycine

    InChi Key: YOZBGTLTNGAVFU-UHFFFAOYSA-N

    InChi Code: InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)

    SMILES Code: O=C(O)CNC(C1=C(O)C2=C(C(C)=N1)C=C(OC3=CC=CC=C3)C=C2)=O



    • 摩尔计算器
    • 稀释计算器
    • The molarity calculator equation

      Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

      • Mass
      • Concentration
      • Volume
      • Molecular Weight *
      • =
      • ×
      • ×
    • The dilution calculator equation

      Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

      This equation is commonly abbreviated as: C1V1 = C2V2

      • Concentration (start)
      • ×
      • Volume (start)
      • =
      • Concentration (final)
      • ×
      • Volume (final)
      • ×
      • =
      • ×
      • C1
      •  
      • V1
      •  
      • C2
      •  
      • V2

    In Vitro

    In vitro activity: FG-4592 is an oral inhibitor of hypoxia inducible factor (HIF) prolyl hydroxylase currently in clinical development for the treatment of anemia. FG-4592 stabilizes the activities of HIF, a cytosolic transcription factor, leading to activation of the genes associated with erythropoiesis, including erythropoietin and enzymes involved in iron metabolism.

     

    Kinase Assay: FG-4592 (also known as ASP1517 and Roxadustat) is a novel, oral and potent small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH), an enzyme up-regulating the expression of endogenous human erythropoietin (Epo). Roxadustat induces EPO production and stimulates erythropoiesis.

     

    Cell Assay: FG-4592 showed significant protection effect against the TBHP-induced cell death. Cell line used: PC-12 cells. The left eye of each rat is retro-orbitally injected with 25 mg/kg FG-4592 every 2 days, and an equal volume of 20% DMSO diluted with 0.9% NaCl is administrated with retro-orbital injection and served as the control. The retinae (attached, 1 day, 3 days, 5 days, and 7 days after RD) are homogenized and lysed with buffer containing 50 mM hydroxymethyl(Tris)-aminomethane(HCl), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, and a protease inhibitor tablet. Samples are run on 8% to 12% 2-hydroxyethyl (Bis)-hydroxymethyl (Tris) gel electrophoresis and transferred onto polyvinylidene difluoride (PVDF) membranes (0.2-mm pores). After blocking with 3% nonfat dried milk, the membranes are incubated overnight with primary antibody HIF-1α, LC3, BNIP3, autophagy-related gene 5 (Atg5), and β-actin. The blotted membranes are then incubated for 60 minutes at room temperature with a horseradish peroxidase (HRP)-labeled secondary antibody. Immunoreactive bands are visualized by enhanced chemiluminescence (ECL) and detected with an Amersham Imager 600. A minimum of three rats are used for each condition.

    In Vivo

    In a mouse model of spinal cord injury, FG-4592 administration improved recovery and increased the survival of neurons in spinal cord lesions

    Animal model

    Mouse model of spinal cord injury

    Formulation & Dosage

    50mg/kg/day; i.p.; for 7 days

    References

    Brain Res. 2016 Feb 1;1632:19-26;


    These protocols are for reference only. InvivoChem does not independently validate these methods.

    Roxadustat (FG-4592)

    Mean change from BL in Hb (ΔHb) in TIW cohorts (EE population). Nephrol Dial Transplant. 2015 Oct;30(10):1665-73.

    Roxadustat (FG-4592)

    Changes in median plasma EPO on first and final days of treatment. Data are for the PK/PD population (subjects with complete dataset only). Nephrol Dial Transplant. 2015 Oct;30(10):1665-73.

    Roxadustat (FG-4592)

    Mean change from BL in serum hepcidin (EE population). Nephrol Dial Transplant. 2015 Oct;30(10):1665-73.


    评论

      Home Prev Next Last page / pices

      发评论

      ×
      你的资料在我们这儿很安全* 必填项。
      InvivoChem的所有产品仅用于作科学研究,不面向患者销售
      电话:020-31522723
      QQ:463611831
      电子邮箱: sales@invivochem.net
      获得最新产品资讯、折扣和优惠
      • 姓名*
      • *
      • 邮箱*
      • *
      • 详细说明:
      • *
      Copyright 2020 InvivoChem LLC | All Rights Reserved